Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Reexamination Certificate
2000-01-18
2001-02-06
Jones, Dameron (Department: 1619)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
C424S001110, C424S009100, C544S053000, C544S058100, C544S224000, C544S242000
Reexamination Certificate
active
06183726
ABSTRACT:
FIELD OF INVENTION
This invention relates generally to novel cyanine and indocyanine dyes for use in imaging, diagnosis and therapy. Particularly, this invention relates to compositions of cyanine and indocyanine dyes wherein novel carbocyclic and heterocyclic moieties are incorporated into the polyene portion of the dye molecules.
BACKGROUND OF THE INVENTION
Several dyes that absorb and emit light in the visible and near-infrared region of electromagnetic spectrum are currently being used for various biomedical applications due to their biocompatibility, high molar absorptivity, or high fluorescence quantum yields. The high sensitivity of the optical modality in conjunction with dyes as contrast agents parallels that of nuclear medicine and permits visualization of organs and tissues without the undesirable effect of ionizing radiation. Cyanine dyes with intense absorption and emission in the near-infrared (NIR) region are particularly useful because biological tissues are optically transparent in this region (B. C. Wilson, Optical properties of tissues.
Encyclopedia of Human Biology,
1991, 5, 587-597). For example, indocyanine green, which absorbs and emits in the NIR region has been used for monitoring cardiac output, hepatic functions, and liver blood flow (Y-L. He, H. Tanigami, H. Ueyama, T. Mashimo, and I. Yoshiya, Measurement of blood volume using indocyanine green measured with pulse-spectrometry: Its reproducibility and reliability.
Critical Care Medicine,
1998, 26(8), 1446-1451; J. Caesar, S. Shaldon, L. Chiandussi, et al., The use of Indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.
Clin. Sci.
1961, 21, 43-57) and its functionalized derivatives have been used to conjugate biomolecules for diagnostic purposes (R. B. Mujumdar, L. A. Ernst, S. R. Mujumdar, et al., Cyanine dye labeling reagents: Sulfoindocyanine succinimidyl esters.
Bioconjugate Chemistry,
1993, 4(2), 105-111; Linda G. Lee and Sam L. Woo. “N-Heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescent labels”, U.S. Pat. No. 5,453,505; Eric Hohenschuh, et al. “Light imaging contrast agents”, WO 98/48846; Jonathan Turner, et al. “Optical diagnostic agents for the diagnosis of neurodegenerative diseases by means of near infra-red radiation”, WO 98/22146; Kai Licha, et al. “In-vivo diagnostic process by near infrared radiation”, WO 96/17628; Robert A. Snow, et al., Compounds, WO 98/48838).
A major drawback in the use of cyanine dye derivatives is the potential for hepatobilliary toxicity resulting from the rapid clearance of these dyes by the liver (G. R. Cherrick, S. W. Stein, C. M. Leevy, et al., Indocyanine green: Observations on its physical properties, plasma decay, and hepatic extraction.
J. Clinical Investigation,
1960, 39, 592-600). This is associated with the tendency of cyanine dyes to form aggregates in solution which could be taken up by Kupffer cells in the liver. Various attempts to obviate this problem have not been very successful. Typically, hydrophilic peptides, polyethyleneglycol or oligosaccharide conjugates have been used but these resulted in long-circulating products which are eventually cleared by the liver. Another major difficulty with current cyanine and indocyanine dye systems is that they offer a limited scope in the ability to induce large changes in the absorption and emission properties of these dyes. Attempts have been made to incorporate various heteroatoms and cyclic moieties into the polyene chain of these dyes (L. Strekowski, M. Lipowska, and G. Patonay, Substitution reactions of a nucleofugal group in hetamethine cyanine dyes.
J. Org. Chem.,
1992, 57, 4578-4580; N. Narayanan, and G. Patonay, A new method for the synthesis of heptamethine cyanine dyes: Synthesis of new near infrared fluorescent labels.
J. Org. Chem.,
1995, 60, 2391-2395; E. Fung and R. Rajagopalan, Monocyclic functional dyes for contrast enhancement in optical imaging, U.S. Pat. No. 5,732,104; R. Rajagopalan and E. Fung, Delta
1,6
bicyclo[4,4,0] functional dyes for contrast enhancement in optical imaging, U.S. Pat. No. 5,672,333; R. Rajagopalan and E. Fung, Tricyclic functional dyes for contrast enhancement in optical imaging, U.S. Pat. No. 5,709,845) but the resulting dye systems do not show large differences in absorption and emission maxima, especially beyond 830 nm where photacoustic diagnostic applications are very sensitive. They also possess prominent hydrophobic core which enhances liver uptake. Further, most cyanine dyes do not have the capacity to form dendrimers which are useful in biomedical applications.
Therefore, there is a need to design novel dyes that could prevent dye aggregation in solution, predisposed to form dendrimers , capable of absorbing or emitting beyond 800 nm, possess desirable photophysical properties, and endowed with tissue-specific targeting capability.
The publications and other materials used herein to support the background of the invention or provide additional details respecting the practice, are incorporated by reference.
SUMMARY OF THE INVENTION
The present invention relates particularly to the novel composition comprising cyanine dyes of general formula 1
wherein a
1
and b
1
vary from 0 to 5; W
1
and X
1
may be the same or different and are selected from the group consisting of —CR
10
R
11
, —O—, —NR
12
, —S—, and —Se; Q
1
is a single bond or is selected from the group consisting of —O—, —S—, —Se—, and —NR
13
; Y
1
and Z
1
may be the same or different and are selected from the group consisting of —(CH
2
)
c
—CO
2
H, —CH
2
—(CH
2
—O—CH
2
)
d
—CH
2
—CO
2
H, —(CH
2
)
e
—NH
2
, —CH
2
—(CH
2
—O—CH
2
)
f
—CH
2
—NH
2
, —(CH
2
)
g
—N(R
14
)—(CH
2
)
h
—CO
2
H, and —(CH
2
)
i
—N(R
15
)—CH
2
—(CH
2
—O—CH
2
)
j
—CH
2
—CO
2
H; R
1
and R
10
to R
15
may be same or different and are selected from the group consisting of—hydrogen, C1-C10 alkyl, C1-C10 aryl, C1-C10 alkoxyl, C1-C10 polyalkoxyalkyl, —CH
2
(CH
2
—O—CH
2
)
c
—CH
2
—OH, C1-C20 polyhydroxyalkyl, C1-C10 polyhydroxyaryl, —(CH
2
)
d
—CO
2
H, —CH
2
—(CH
2
—O—CH
2
)
e
—CH
2
—CO
2
H, —(CH
2
)
f
—NH
2
, and —CH
2
—(CH
2
—O—CH
2
)
g
—CH
2
—NH
2
; c, e, g, h, and i vary from 1 to 10; d, f and j vary from 1 to 100; and R
2
to R
9
may be the same or different and are selected from the group consisting of hydrogen, C1-C10 alkyl, C1-C10 aryl, hydroxyl, C1-C10 polyhydroxyalkyl, C1-C10 alkoxyl, amino, C1-C10 aminoalkyl, cyano, nitro and halogen.
The present invention also relates to the novel composition comprising indocyanine dyes of general formula 2
wherein a
2
and b
2
are defined in the same manner as a
1
and b
1
; W
2
and X
2
are defined in the same manner W
1
and X
1
; Q
2
is defined in the same manner as Q
1
; R
16
and R
10
to R
15
are defined in the same manner as R
1
and R
10
to R
15
; Y
2
is defined in the same manner as Y
1
; Z
2
is defined in the same manner as Z
1
; and R
17
to R
28
are defined in the same manner as R
2
to R
9
.
The present invention also relates to the novel composition comprising cyanine dyes of general formula 3
wherein a
3
and b
3
are defined in the same manner as a
1
and b
1
; W
3
and X
3
are defined in the same manner W
1
and X
1
; Y
3
is defined in the same manner as Y
1
; Z
3
is defined in the same manner as Z
1
; A
1
is a single or a double bond; if A
1
is a single bond, then B
1
and C
1
may the same or different and are selected from the group consisting of —O—, —S—, —Se—, —P—, and —NR
38
and D
1
is selected from the group consisting of —CR
39
R
40
, and —C═O; if A
1
is a double bond, then B
1
is selected from the group consisting of —O—, —S—, —Se—, —P—and —NR
38
, C
1
is nitrogen or —CR
41
, and D
1
is —CR
42
; R
29
to R
37
are selected from the group consisting of hydrogen, C1-C10 alkyl, C1-C10 aryl, hydroxyl, hydrophilic peptide, C1-C10 polyhydroxyalkyl, C1-C10 alkoxyl, cyano, nitro, halogen and —NR
43
R
44
; R
38
to R
42
may be same or different and are selected from the group consisting of—hydrogen, C1-C10 alkyl, C1-C10 aryl, C1-C10 alkoxyl,
Achilefu Samuel
Bugaj Joseph E.
Dorshow Richard B.
Rajagopalan Raghavan
Jones Dameron
Limpus Lawrence L.
Mallinckrodt Inc.
LandOfFree
Versatile hydrophilic dyes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Versatile hydrophilic dyes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Versatile hydrophilic dyes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2579543